Table 2.
Model evaluation measures | Base | CCI model | PRI model |
---|---|---|---|
Global measures | |||
LR χ2 | 10,556 | 14,623 | 14,834 |
P-value* | <0.01 | <0.01 | <0.01 |
BIC | 32,269 | 28,213 | 28,003 |
R2 (%) | 24.8% | 34.3% | 34.8% |
Brier (%) | 3.9% | 3.5% | 3.5% |
Discrimination | |||
C-index (%) | 86.9% | 91.3% | 91.5% |
NRI (%) | – | 74.5% | 84.0% |
IDI (%) | – | 9.9% | 10.7% |
† | – | 2.6% | 2.8% |
Notes: Models include the base model with sex and age, the model including sex, age, and Charlson Comorbidity Index (CCI), and the model including sex, age, and the Patient Register Index (PRI), using an internal tenfold cross-validation procedure.
P-value for LR test between the base model and a model including CCI or PRI;
Abbreviations: LR, likelihood ratio; BIC, Bayesian information criterion; NRI, net reclassification improvement; IDI, integrated discrimination improvement.